Appointment New Patient Appointment or 214-645-8300

MedBlog

Search Results

Results: Articles

Cancer; Women's Health

PARP-1 inhibitors can reduce ovarian cancer recurrence risk by 70% in half of patients

PARP-1 inhibitor drugs can reduce the risk of BRCA- and HRDS-associated ovarian cancer by 70%. New research at UT Southwestern Medical Center may help expand treatment to more patients.